Publication | Closed Access

Characterization of novel anthracycline prodrugs activated by human β-glucuronidase for use in antibody-directed enzyme prodrug therapy

Medicinal ChemistryHuman β-GlucuronidaseMedicineImmunologyNovel Anthracycline ProdrugsBioconjugationImmunochemistryAntibody EngineeringAntibody ScreeningPharmacologyDrug Discovery